Application 215870

Type
NDA
Sponsor
EXELA PHARMA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001FENTANYL CITRATEFENTANYL CITRATESOLUTION;INTRAVENOUSEQ 2.5MG BASE/50ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**YesNo
002FENTANYL CITRATEFENTANYL CITRATESOLUTION;INTRAVENOUSEQ 5MG BASE/100ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**YesNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
84633SUPPL 2026-01-05
84587SUPPL 2025-12-29
77063SUPPL 2023-12-19
76975SUPPL 2023-12-19
75518ORIG 2023-09-20
73437ORIG 2023-02-09
73429ORIG 2023-02-09